This article was written at the end of last year prior to the recent IPO. One thing of interest is the 20 year sale agreement with Zimmer Biomet (market cap $24.55 Billion) and the worldwide distribution agreement with 3M ($126.05 Billion). I also note that there is a forecast of $20 million sales for 2019 which was not on the current prospectus for various reasons. But if the trajectory is true this would potentially represent revenue growth of over 600% vs 2018 revenue. DYOR and GLTAH!
- Forums
- ASX - By Stock
- NXS
- How the rich invest: Lang Walker backs Next Science's bacteria buster
How the rich invest: Lang Walker backs Next Science's bacteria buster
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXS (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $56.97M |
Open | High | Low | Value | Volume |
19.5¢ | 19.5¢ | 19.5¢ | $5.102K | 26.16K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 74952 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 35987 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 74952 | 0.195 |
1 | 52578 | 0.190 |
2 | 86599 | 0.185 |
5 | 84233 | 0.180 |
2 | 21000 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 35987 | 2 |
0.205 | 15000 | 1 |
0.215 | 7298 | 1 |
0.220 | 36214 | 1 |
0.225 | 4444 | 1 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
NXS (ASX) Chart |